Uptake of Cationized Albumin Coupled Liposomes by Cultured Porcine Brain Microvessel Endothelial Cells and Intact Brain Capillaries

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of drug targeting (Print)

• Publication date

  2002-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1080/10611860290031840PMID 12164382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System

  2000cited by this paper
• Examination of Blood‐Brain Barrier Transferrin Receptor by Confocal Fluorescent Microscopy of Unfixed Isolated Rat Brain Capillaries

  1998cited by this paper
• Modulation of morphine-6-glucuronide penetration into the brain by P-glycoprotein.

  1998cited by this paper
• Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

  1997cited by this paper
• A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

  1997cited by this paper
• Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels.

  1997cited by this paper
• Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.

  1997cited by this paper
• Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.

  1996cited by this paper
• Blood‐brain‐barrier Transport of Lipid Microspheres Containing Clinprost, a Prostaglandin I2 Analogue

  1996cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium

  1996cited by this paper
• Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

  1995cited by this paper
• Brain Delivery of Biotin Bound to a Conjugate of Neutral Avidin and Cationized Human Albumin

  1994cited by this paper
• Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers

  1994cited by this paper
• Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules

  1994cited by this paper
• Specific uptake of succinylated proteins via a scavenger receptor-mediated mechanism in cultured brain microvessel endothelial cells.

  1993cited by this paper
• Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

  1993cited by this paper
• Development of a procedure for coupling the homing device glu-plasminogen to liposomes.

  1992cited by this paper
• Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

  1991cited by this paper
• Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.

  1989influential reference
• Characterization of γ-glutamyl transpeptidase activity of cultured endothelial cells from porcine brain capillaries

  1989cited by this paper
• Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport.

  1987cited by this paper
• Rapid Sequestration and Degradation of Somatostatin Analogues by Isolated Brain Microvessels

  1985influential reference
• Transferrin receptor on endothelium of brain capillaries

  1984cited by this paper
• Rapid, reversible internalization of cell surface insulin receptors. Correlation with insulin-induced down-regulation.

  1983influential reference
• A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay.

  1983cited by this paper
• Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones

  1980cited by this paper
• Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.

  1980cited by this paper
• Isolation of metabolically active capillaries from rat brain 1, 2

  1975influential reference
• Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method.

  1970influential reference
• Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation.

  1970influential reference
• A method for the quantitative modification and estimation of carboxylic acid groups in proteins.

  1967cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Recent advances in potential drug nanocarriers for CNS disorders: a review

  2025cites this paper
• Smart liposomal systems for brain cancer: Technological innovations in drug delivery.

  2025cites this paper
• Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

  2024cites this paper
• Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier.

  2023cites this paper
• Functionalized liposomes: an enticing nanocarrier for management of glioma

  2023cites this paper
• Liposomes for the Treatment of Brain Cancer—A Review

  2023cites this paper
• Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases

  2023cites this paper
• Engineered nanomaterials that exploit blood-brain barrier dysfunction fordelivery to the brain.

  2023cites this paper
• Recent advances in lipid-protein conjugate-based delivery systems in nutraceutical, drug, and gene delivery

  2022cites this paper
• The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.

  2022cites this paper
• Preparation of cationized albumin nanoparticles loaded indirubin by high pressure hemogenizer

  2021cites this paper
• Dual-modified albumin-polymer nanocomplexes with enhanced in vivo stability for hepatocellular carcinoma therapy.

  2021cites this paper
• Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

  2021cites this paper
• Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses

  2021cites this paper
• Extended-release of therapeutic microRNA via a host-guest supramolecular hydrogel to locally alleviate renal interstitial fibrosis.

  2021cites this paper
• The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood-brain barrier and attenuates their targeting ability to brain tumor.

  2021cites this paper
• Evolving new-age strategies to transport therapeutics across the blood-brain-barrier.

  2021cites this paper
• Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.

  2020cites this paper
• Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

  2020cites this paper
• Key for crossing the BBB with nanoparticles: the rational design

  2020cites this paper
• Fatty-Amine-Conjugated Cationic Bovine Serum Albumin Nanoparticles for Target-Specific Hydrophobic Drug Delivery

  2019cites this paper
• Endocytosis acts as transport pathway in wood.

  2019cites this paper
• Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors

  2019cites this paper
• Sugar ligand-mediated drug delivery.

  2019cites this paper
• Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis.

  2019cites this paper
• Unraveling In Vivo Brain Transport of Protein-Coated Fluorescent Nanodiamonds.

  2019cites this paper
• Application of glycosylation in targeted drug delivery.

  2019cites this paper
• Brain drug delivery by adsorption-mediated transcytosis

  2019cites this paper
• Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment

  2018cites this paper
• Theranostic size‐reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis

  2018cites this paper
• Targeted Theranostic Nanoparticles for Brain Tumor Treatment

  2018cites this paper
• Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting

  2018cites this paper
• Chapter 8 Liposomal Drug Delivery to the Central Nervous System

  2018cites this paper
• In silico study of liposome transport across biomembranes

  2018cites this paper
• Redox responsive albumin autogenic nanoparticles for the delivery of cancer drugs.

  2017cites this paper
• Polymer Nanomaterials for Drug Delivery Across the Blood Brain Barrier

  2017cites this paper
• Protein‐lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes

  2017cites this paper
• Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.

  2017cites this paper
• Liposomal Drug Delivery to the Central Nervous System

  2017cites this paper
• Polymer Particulates in Drug Delivery.

  2016cites this paper
• Liposome size and charge optimization for intraarterial delivery to gliomas

  2016cites this paper
• Nanoparticulate Drug Delivery Systems

  2016cites this paper
• Delivery of Copper-chelating Trientine (TETA) to the central nervous system

  2016cites this paper
• Cationic bovine serum albumin (CBA) conjugated poly lactic-co-glycolic acid (PLGA) nanoparticles for extended delivery of methotrexate into brain tumors

  2016cites this paper
• Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain

  2016cites this paper
• Liposomal Conjugates for Drug Delivery to the Central Nervous System

  2015cites this paper
• Cationic Albumin‐Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration

  2015cites this paper
• Targeted Drug Delivery Systems: Strategies and Challenges

  2015cites this paper
• Lipids as Biological Materials for Nanoparticulate Delivery

  2014cites this paper
• Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.

  2014cites this paper
• Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis.

  2013cites this paper
• Recent Advances on Nanotechnology Applications to Cancer Drug Therapy

  2013cites this paper
• A simple method to quickly and simultaneously purify and enrich intact rat brain microcapillaries and endothelial and glial cells for ex vivo studies and cell culture.

  2013cites this paper
• In silico, in vitro and in vivo methods to analyse drug permeation across the blood-brain barrier: A critical review

  2013cites this paper
• Medicinal Chemistry Based Approaches and Nanotechnology‐Based Systems to Improve CNS Drug Targeting and Delivery

  2013cites this paper
• OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability

  2012cites this paper
• Nanoparticulate targeted drug delivery using peptides and proteins

  2012cites this paper
• Adsorptive-mediated brain delivery systems.

  2012cites this paper
• Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.

  2012cites this paper
• Improving the transport of chemotherapeutic drugs across the blood–brain barrier

  2011cites this paper
• Targeting of nanoparticles in cancer: drug delivery and diagnostics

  2011cites this paper
• Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development

  2011cites this paper
• Lipid-based drug delivery systems for cancer treatment.

  2011cites this paper
• Albumin coated liposomes: a novel platform for macrophage specific drug delivery

  2011cites this paper
• An investigation of the use of dendrimer-based carrier to cross cellular barrier

  2011cites this paper
• Drug Targeting to the Central Nervous System

  2011cites this paper
• Drug transport and the blood-brain barrier

  2011cites this paper
• Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.

  2011cites this paper
• Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.

  2011cites this paper
• Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system

  2011cites this paper
• Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.

  2010cites this paper
• Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.

  2010cites this paper
• Drug delivery to the CNS and polymeric nanoparticulate carriers.

  2010cites this paper
• Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

  2010cites this paper
• Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147.

  2010cites this paper
• Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.

  2010cites this paper
• Interaktionen verschiedener Formulierungen von Poly(n-butylcyanoacrylat)-Nanopartikeln mit der Blut-Hirn-Schranke in vivo und in vitro

  2010cites this paper
• A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.

  2010cites this paper
• Chapter 3 - Colloidal systems for CNS drug delivery.

  2009cites this paper
• Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.

  2009cites this paper
• Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries

  2009cites this paper
• Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles

  2009cites this paper
• Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.

  2009cites this paper
• Delivery of peptide and protein drugs over the blood-brain barrier.

  2009cites this paper
• Nanoparticles as novel carrier for brain delivery: a review.

  2009cites this paper
• Delivery of nanoparticles to the brain detected by fluorescence microscopy.

  2008cites this paper
• CNS Delivery Via Adsorptive Transcytosis

  2008cites this paper
• Potential of solid lipid nanoparticles in brain targeting.

  2008cites this paper
• Insight into the role of HSPG in the cellular uptake of apolipoprotein E-derived peptide micelles and liposomes.

  2008cites this paper
• In Vitro Models to Study Blood-Brain Barrier Function

  2008cites this paper
• A Mathematical Model for the Transport of Paclitaxel (Taxol) Across the Blood-Brain Barrier

  2007cites this paper
• Active targeting of brain tumors using nanocarriers.

  2007cites this paper
• Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.

  2007cites this paper
• Transcytotic passage of albumin through lens epithelial cells.

  2007cites this paper
• Nanoparticulate Systems for Central Nervous System Drug Delivery

  2007cites this paper
• Immunociblage du cerveau par des nanocapsules lipidiques

  2007cites this paper
• Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

  2007cites this paper
• Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

  2007cites this paper
• Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.

  2006cites this paper
• The blood-brain barrier and brain drug delivery.

  2006cites this paper